Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines

The killed bivalent (O1 and O139) whole cell oral cholera vaccine (OCV) (Shanchol™) was first licensed in India in 2009 and World Health Organization pre-qualified in 2011. We assessed the safety and immunogenicity of this OCV in the Philippines. This was a phase IV, single-arm, descriptive, open-la...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Capeding, Maria Rosario Z., Gonzales, Maria Liza Antoinette M., Dhingra, Mandeep Singh, D'Cor, Naveena Aloysia, Midde, Venkat Jayanth, Patnaik, Badri Narayan, Thollot, Yaël, Desauziers, Eric
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5975480/
https://ncbi.nlm.nih.gov/pubmed/28910563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1342908
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados